Part, Chapter, Paragraph
1 I, 2. 5 | public — clients, customers, patients and so forth — which can
2 I, 2. 10. 3| health professionals and patients.~ ~Activities under the
3 I, 2. 10. 4| products, medical devices, patients, caregivers, assets, equipment
4 I, 2. 10. 4| calculated that approximately 60 patients die each day due to adverse
5 I, 2. 10. 4| wards, working directly with patients and ward staff19. The implementation
6 II, 5. 1. 1| producing cells, meaning that patients with the disease eventually
7 II, 5. 1. 1| CKD at population level. Patients with neoplasias and with
8 II, 5. 1. 1| viral hepatitis (HBC) and patients exposed to nephrotoxic drugs
9 II, 5. 1. 1| than 22% of the incident patients.~Food Allergy~In adults,
10 II, 5. 1. 1| worsen periodontal status of patients already affected by periodontitis
11 II, 5. 1. 3| the interactions between patients and physicians and a good
12 II, 5. 1. 3| education should enable patients to acquire and maintain
13 II, 5. 1. 3| has been designed to help patients and their families understand
14 II, 5. 1. 3| hoping therefore to improve patients’ autonomy and self-management.
15 II, 5. 1. 3| long-term accompaniment of patients where the various characteristics –
16 II, 5. 1. 3| trained in the education of patients that takes into account:~·
17 II, 5. 1. 3| subjective and objective needs of patients, whether expressed or not.
18 II, 5. 1. 3| providers tend to talk to patients about their disease rather
19 II, 5. 1. 3| designed, therefore, to train patients in the skills of self-managing
20 II, 5. 1. 3| cost of long-term care for patients and our society. Therapeutic
21 II, 5. 1. 3| conditions, although acutely ill patients should not be excluded from
22 II, 5. 1. 3| trained in the education of patients, and designed to enable
23 II, 5. 1. 3| a patient (or a group of patients and families) to manage
24 II, 5. 1. 4| 5.1.4. Participation of patients in society~ ~A person affected
25 II, 5. 1. 4| their rights and duties as patients.~ ~· In the family: information
26 II, 5. 2. 1| an improved survival of patients with CVD.~The burden of
27 II, 5. 2. 3| Allender et al, 2008). Most AMI patients who receive a CABG do not
28 II, 5. 2. 3| perform PTCA in high-risk patients with vessel obstruction:
29 II, 5. 2. 3| the surgery performed on patients with AMI and that performed
30 II, 5. 2. 3| AMI and that performed on patients with IHD.~ ~Table 5.2.3.
31 II, 5. 2. 3| case fatality (including patients dying before reaching hospital);
32 II, 5. 2. 3| therefore the large number of patients suffering from strokes.~
33 II, 5. 2. 4| case-control study, conducted in patients with myocardial infarction
34 II, 5. 2. 4| properly followed, even in patients which have already experienced
35 II, 5. 2. 4| factors in hospitalized patients with IHD and determine whether
36 II, 5. 2. 4| years the prevalence of patients with hypertension undergoing
37 II, 5. 2. 4| of statins, about 60% of patients with hyperlipidemia are
38 II, 5. 2. 6| mg/dL in very high risk patients to 160 mg/dL in very low
39 II, 5. 2. 6| feasible, in diabetic or patients with established CVD) (Graham
40 II, 5. 3. 1| survival experience of cancer patients, after removing the effects
41 II, 5. 3. 2| recorded for all cancer patients. For those countries with
42 II, 5. 3. 2| minorities;~- cancer survival for patients living in poor areas is
43 II, 5. 3. 2| genetic epidemiology and on patients’ quality of life. For all
44 II, 5. 3. 2| to treatment for cancer patients and availability of new
45 II, 5. 3. 3| is lower in the elderly patients than in the younger ones.
46 II, 5. 3. 6| population-based cancer registries on patients survival in various European
47 II, 5. 3. 6| Adult cancer survival~ ~Patients diagnosed in 1990-1994~Survival
48 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
49 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
50 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
51 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
52 II, 5. 3. 6| women, younger and older patients, and rectal and colon cancer
53 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
54 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
55 II, 5. 3. 6| Survival for lung cancer patients remains poor, with age-adjusted
56 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
57 II, 5. 3. 6| relative survival by sex. Patients diagnosed between 1990 and
58 II, 5. 3. 6| rates were already high for patients diagnosed in the 1980s.
59 II, 5. 3. 6| year relative survival. Patients diagnosed between 1990 and
60 II, 5. 3. 6| year relative survival. Patients diagnosed between 1990 and
61 II, 5. 3. 6| year relative survival. Patients diagnosed between 1990 and
62 II, 5. 3. 6| to 31st December 1999~ ~Patients diagnosed in 1995-1999~Berrino
63 II, 5. 3. 6| their health resources.~ ~Patients diagnosed in 2000-2002~Verdecchia
64 II, 5. 3. 6| analysed survival data for patients diagnosed with cancer in
65 II, 5. 3. 6| period relative survival for patients diagnosed in 2000–02 was
66 II, 5. 3. 6| period survival improved for patients diagnosed in 2000–02, especially
67 II, 5. 3. 6| 2000–02, especially for patients with colorectal, breast,
68 II, 5. 3. 6| lung cancer. Survival for patients diagnosed in 2000–02 was
69 II, 5. 3. 6| European countries, although, patients in Eastern Europe had the
70 II, 5. 3. 7| quality of life for cancer patients. This is achieved by transferring
71 II, 5. 3. 7| successful treatment of cancer patients due to detection at an earlier
72 II, 5. 3. 7| regarding the ability of patients to access new innovative
73 II, 5. 3. 7| among, for example, elderly patients, often not included in pivotal
74 II, 5. 3. 7| monitored;~· Most cancer patients need care for diagnosis
75 II, 5. 3. 8| factors. Moreover, cancer patients survival in Europe has strongly
76 II, 5. 3. 8| resources to follow-up cancer patients and identify and treat cancer
77 II, 5. 3. 8| resources to follow-up cancer patients and identify and treat cancer
78 II, 5. 3. 8| research organizations, patients and stakeholders.~ ~Short-term
79 II, 5. 3. 8| treatment and care to cancer patients, exchange information on
80 II, 5. 3. 9| EUROCARE-3: survival of cancer patients diagnosed 1990-94. Results
81 II, 5. 4. 1| be restored to safeguard patients' survival. Symptoms rapidly
82 II, 5. 4. 1| the quality of life and patients' outcomes on an everyday
83 II, 5. 4. 1| is fundamental to empower patients and involve them in reducing
84 II, 5. 4. 2| Governmental Health Departments and Patients’ Associations from EU countries
85 II, 5. 4. 2| Cardiovascular mortality in patients with diabetes~ ~ ~ ~
86 II, 5. 4. 2| outcomes experienced by patients identified with a diagnosis
87 II, 5. 4. 2| other databases: diabetic patients may be identified by other
88 II, 5. 4. 2| hide part of the results as patients may be discharged when conditions
89 II, 5. 4. 2| pharmaceutical use made by diabetic patients.~A limitation of this method
90 II, 5. 4. 2| information on undiagnosed patients and the general population.
91 II, 5. 4. 2| networks, all diagnosed patients will be included in statistical
92 II, 5. 4. 2| insurances only includes patients receiving a treatment or
93 II, 5. 4. 2| diagnosed and undiagnosed patients which is impossible health
94 II, 5. 4. 2| renal replacement therapy in patients with diabetes/1,000,000
95 II, 5. 4. 2| replacement therapy) in patients with diabetes /1,000,000
96 II, 5. 4. 2| Registries~Annual death rate in patients who have as primary or any
97 II, 5. 4. 2| the annual death rate in patients who have as primary or any
98 II, 5. 4. 2| diabetes coma, most diabetic patients die from macrovascular complications,
99 II, 5. 4. 2| but medical) in diabetic patients /100,000 general population~
100 II, 5. 4. 2| incidence of stroke in diabetic patients /100,000 general population~
101 II, 5. 4. 2| myocardial infarction in diabetic patients/100,000 general population~
102 II, 5. 4. 3| cholesterol. The decrease in patients above 75 may reflect a decline
103 II, 5. 4. 3| Spain) per 100,000 diabetes patients, with a median of 226, corresponding
104 II, 5. 4. 4| differential selection, as blind patients are harder to reach and
105 II, 5. 4. 4| concerns dialysis, for which patients are unfortunately urged
106 II, 5. 4. 4| Moreover, between 25-60% of the patients are poorly controlled for
107 II, 5. 4. 5| producing cells, meaning that patients with the disease may eventually
108 II, 5. 4. 6| as 50% of non-diagnosed patients (prior to complications),
109 II, 5. 4. 6| et al. 2007) investigated patients with acute myocardial infarction (
110 II, 5. 4. 6| impaired glucose tolerance in patients with AMI. The importance
111 II, 5. 4. 6| systems among clinicians and patients would be highly beneficial
112 II, 5. 5.Int| meantime, European networks of patients’ organizations (e.g. Mental
113 II, 5. 5.Int| organizations are advocating the patients’ needs in areas regarding
114 II, 5. 5.Int| promoting the empowerment of patients and their families; the
115 II, 5. 5. 1| of all registered mental patients at the end of a calendar
116 II, 5. 5. 1| include institutionalised patients and do not take into account
117 II, 5. 5. 3| hospitalization dynamics in patients with eating disorders, territorial
118 II, 5. 5. 3| about one quarter of the patients exhibits only one acute
119 II, 5. 5. 3| psychiatric services of patients with the diagnosis of schizophrenia;
120 II, 5. 5. 3| diagnosis of schizophrenia; patients not receiving specialized
121 II, 5. 5. 3| schizophrenia since about 80% of patients are treated in settings
122 II, 5. 5. 3| information on the care of patients with schizophrenia.~ ~Inter-country
123 II, 5. 5. 3| reflect the actual use in patients with schizophrenia since
124 II, 5. 5. 3| were prescribed to treat patients with schizophrenia (IMS
125 II, 5. 5. 3| significantly between physicians and patients.~There is also a need to
126 II, 5. 5. 3| prognosis. About 50% of the patients with schizophrenia are addicted
127 II, 5. 5. 3| therapists, since these patients experience frequent relapses,
128 II, 5. 5. 3| shown to be about 15% in patients with schizophrenia as compared
129 II, 5. 5. 3| efficacy of psychotherapy for patients with schizophrenia (Pitschel-Walz
130 II, 5. 5. 3| optimizing the treatment of patients with schizophrenia, an important
131 II, 5. 5. 3| indications that a number of patients with schizophrenia receive
132 II, 5. 5. 3| discontinuation over 12 months in patients with first-episode schizophrenia
133 II, 5. 5. 3| significantly greater in patients given a low dose of haloperidol
134 II, 5. 5. 3| found that, in general, patients reported a need for help
135 II, 5. 5. 3| schizophrenia and three with patients’ relatives) (Figure 5.5.
136 II, 5. 5. 3| indirect costs in a cohort of patients with schizophrenia over
137 II, 5. 5. 3| stigma of schizophrenia from patients’ and relatives’ view: A
138 II, 5. 5. 3| medical services for their patients? J Ment Health Policy Econ
139 II, 5. 5. 3| medication nonadherence in patients with schizophrenia: A comprehensive
140 II, 5. 5. 3| Nordic Study on schizophrenic patients living in the community.
141 II, 5. 5. 3| Prevalence of obesity in patients receiving depot antipsychotics.
142 II, 5. 5. 3| for at least five years in patients still receiving antiepileptic
143 II, 5. 5. 3| for at least five years in patients off medications at the time
144 II, 5. 5. 3| cryptogenic seizures), in patients with previous stable (non-progressing)
145 II, 5. 5. 3| recurrent. Although all patients with single unprovoked seizures
146 II, 5. 5. 3| condition, about two-thirds of patients achieve seizure remission,
147 II, 5. 5. 3| 4.2. Data sources~ ~The patients with epilepsy enrolled in
148 II, 5. 5. 3| have been conducted on all patients with epilepsy or in patients
149 II, 5. 5. 3| patients with epilepsy or in patients in different age groups (
150 II, 5. 5. 3| instances, in the majority of patients with epilepsy no cause can
151 II, 5. 5. 3| population-based cohort of patients with childhood-onset epilepsy
152 II, 5. 5. 3| of mortality in epilepsy. Patients with symptomatic epilepsy
153 II, 5. 5. 3| the general population. Patients with a CNS lesion presumed
154 II, 5. 5. 3| In the Finnish cohort of patients with childhood epilepsy
155 II, 5. 5. 3| Sillanpaa et al, 1998), patients not in remission had a 9.
156 II, 5. 5. 3| 3.8-22.7) compared with patients in 5-year remission. There
157 II, 5. 5. 3| regarding the mortality in patients with partial seizures are
158 II, 5. 5. 3| Gaitatzis and Sander, 2004). Patients with epilepsy are reported
159 II, 5. 5. 3| different methods of analysis. Patients with severe epilepsy have
160 II, 5. 5. 3| epilepsy have a fivefold and patients with temporal lobe epilepsy
161 II, 5. 5. 3| 87.5; 95% CI 35-180) in patients with temporal lobe epilepsy
162 II, 5. 5. 3| increased risk of suicide in patients with epilepsy. While seizure-related
163 II, 5. 5. 3| in new onset epilepsy, in patients with chronic epilepsy most
164 II, 5. 5. 3| Nashef et al, 1996).~In patients undergoing epilepsy surgery,
165 II, 5. 5. 3| SMR and SUDEP in surgical patients, the SMR (all causes) was
166 II, 5. 5. 3| 6-18.4) in non-surgical patients, while the incidence of
167 II, 5. 5. 3| prevalence of comorbidity in patients with epilepsy (Gaitatzis
168 II, 5. 5. 3| by 24 months was 86% in patients with epilepsy and 75% in
169 II, 5. 5. 3| disease classification. Patients with and without epilepsy
170 II, 5. 5. 3| with PR greater than 10 in patients aged 16-64 and greater than
171 II, 5. 5. 3| 64 and greater than 5 in patients 65+. A greater than two-
172 II, 5. 5. 3| comorbidity was found in patients aged 16 to 64, organic psychoses,
173 II, 5. 5. 3| most common conditions. In patients aged 65 or more alcohol
174 II, 5. 5. 3| In the Finnish cohort of patients with childhood-onset epilepsy,
175 II, 5. 5. 3| comparable levels of education in patients with epilepsy and non-epileptic
176 II, 5. 5. 3| are generally higher in patients with epilepsy than in the
177 II, 5. 5. 3| restrictions adopted in patients with epilepsy. However,
178 II, 5. 5. 3| fairly low (15%) in adult patients with newly diagnosed idiopathic
179 II, 5. 5. 3| variability of exceptions for patients with active epilepsy (seizures
180 II, 5. 5. 3| poor seizure control affect patients’ education, employment,
181 II, 5. 5. 3| discriminating reasons for patients with epilepsy Although one
182 II, 5. 5. 3| society towards epilepsy, patients with epilepsy still face
183 II, 5. 5. 3| education on epilepsy towards patients, their relatives and all
184 II, 5. 5. 3| based on small samples of patients. For this reason, a study
185 II, 5. 5. 3| be performed to identify patients with acute symptomatic seizures,
186 II, 5. 5. 3| seizures (epilepsy). Cohorts of patients with a first seizure should
187 II, 5. 5. 3| recurrence and identify patients at high risk of epilepsy.~
188 II, 5. 5. 3| employment and driving in patients with epilepsy and the scarce
189 II, 5. 5. 3| high standards of care to patients with epilepsy to reduce
190 II, 5. 5. 3| problems posed by individual patients and exchange information
191 II, 5. 5. 3| Morbidity and accidents in patients with epilepsy: results of
192 II, 5. 5. 3| Jallon P (2004): Mortality in patients with epilepsy’ Curr Opin
193 II, 5. 5. 3| study of more than 9,000 patients once hospitalized for epilepsy.
194 II, 5. 5. 3| cohort of epilepsy surgery patients. Epilepsia 44:575-581.~O’
195 II, 5. 5. 3| et al (2002): Survival of patients with epilepsy: an estimate
196 II, 5. 5. 3| other causes of death in patients with epilepsy. Neurology
197 II, 5. 5. 3| group (2004): Accidents in patients with epilepsy: types, circumstances
198 II, 5. 5. 3| symptoms such as fatigue (80% patients) can alone interfere with
199 II, 5. 5. 3| information of all prevalent MS patients in Norway (Myhr et al, 2006; www ).
200 II, 5. 5. 3| serum) from all available MS patients was implemented.~ ~In 2001,
201 II, 5. 5. 3| epidemiological data on the number of patients with MS, course of the disease,
202 II, 5. 5. 3| data sets of ca. 5800 MS patients were recorded from 82 centers (
203 II, 5. 5. 3| Proportion of Multiple Sclerosis patients by disease course in selected
204 II, 5. 5. 3| Proportion of Multiple Sclerosis patients by disease severity (EDSS)
205 II, 5. 5. 3| over time. Also, when MS patients die from other causes or
206 II, 5. 5. 3| Mortality (per 100 000) of MS patients in selected EUGLOREH countries~ ~
207 II, 5. 5. 3| intangible costs (comparison of patients’ HRQoL to that of age- and
208 II, 5. 5. 3| of total costs) to help patients in their activities of daily
209 II, 5. 5. 3| to these new indications, patients can receive a diagnosis
210 II, 5. 5. 3| shows heterogeneity among patients and can be rather unpredictable
211 II, 5. 5. 3| m; 7.0 to 9.5 refers to patients restricted to wheelchairs,
212 II, 5. 5. 3| treatment is warranted in all patients with MS or at risk of developing
213 II, 5. 5. 3| life and productivity of MS patients’ . An understanding of the
214 II, 5. 5. 3| drugs is critical for the patients to ensure compliance. Other
215 II, 5. 5. 3| published studies on MS patients and their employment situation
216 II, 5. 5. 3| of Best Practice” for MS patients.~European Code of Good Practice
217 II, 5. 5. 3| the optimised care of MS patients. The multiple sclerosis
218 II, 5. 5. 3| underlines the need for patients severely affected by MS
219 II, 5. 5. 3| also part of the European Patients’ Forum and the European
220 II, 5. 5. 3| Consultative status for patients on issues such as pricing
221 II, 5. 5. 3| and functional status of patients in Csongrád County, Hungary.
222 II, 5. 5. 3| Hyllested K (1994): Survival of patients with multiple sclerosis
223 II, 5. 5. 3| cause of death in Damish patients with multiple sclerosis.
224 II, 5. 5. 3| number of multiple sclerosis patients in germany]. Nervenartz
225 II, 5. 5. 3| associated with unemployment of patients with MS. Journal of Chronic
226 II, 5. 5. 3| approximately 10% of the patients are younger than 50 years
227 II, 5. 5. 3| mean duration of 12 years, patients require assistance with
228 II, 5. 5. 3| estimated the number of PD patients at 1.2 million within the
229 II, 5. 5. 3| 000 for institutionalised patients in Germany (Evers and Obladen,
230 II, 5. 5. 3| for healthcare planning: patients in advanced stages of PD
231 II, 5. 5. 3| healthcare expenditures than patients in the early stages of the
232 II, 5. 5. 3| accepted way of stratifying patients according to the severity
233 II, 5. 5. 3| studies, more than 55% of the patients were classified as stage
234 II, 5. 5. 3| English study, only 27% of patients were classified as stage
235 II, 5. 5. 3| probabilities of participation by patients with mild symptomatology
236 II, 5. 5. 3| the case for elderly PD patients, patients with advanced
237 II, 5. 5. 3| for elderly PD patients, patients with advanced disease have
238 II, 5. 5. 3| widely believed that PD patients do have the benefit of improved
239 II, 5. 5. 3| study, which followed PD patients over a 10-year time-period,
240 II, 5. 5. 3| Comorbidity is common in patients with PD and psychiatric
241 II, 5. 5. 3| occur in up to 70% of PD patients during the advanced stage (
242 II, 5. 5. 3| quality of life in those patients (Global Parkinson’s Disease
243 II, 5. 5. 3| nursing home placement in PD patients (Aarsland et al, 2000; Goetz
244 II, 5. 5. 3| for severely disabled PD patients reach €9,200 per patient (
245 II, 5. 5. 3| Späte et al, 1988). In patients with a disease onset after
246 II, 5. 5. 3| income loss was observed. In patients with an earlier disease
247 II, 5. 5. 3| group, only 51.2% of the PD patients were still at work compared
248 II, 5. 5. 3| of disease. 25% of the PD patients were no longer working within
249 II, 5. 5. 3| für Gesundheit, 1995). PD patients retired at a mean age of
250 II, 5. 5. 3| Singer 1973). The rates of patients not working among those
251 II, 5. 5. 3| is notable; 29% out of 72 patients stopped working due to PD (
252 II, 5. 5. 3| and alcohol use in 144 PD patients and 464 matched controls.
253 II, 5. 5. 3| promoting education on PD for patients, their relatives and the
254 II, 5. 5. 3| most of the advanced PD patients supposedly live in nursing
255 II, 5. 5. 3| access to healthcare. Many PD patients are unaware of their diagnosis
256 II, 5. 5. 3| severity in a cohort of French patients with Parkinson’s disease.
257 II, 5. 5. 3| Cognitive impairment in 873 patients with idiopathic Parkinson’
258 II, 5. 5. 3| long-term care of parkinsonian patients. Psychiatr Neurol Med Psychol:
259 II, 5. 6. 3| conditions are major reason for patients to seek expert referral
260 II, 5. 6. 3| Over three quarters of patients presenting to practitioners
261 II, 5. 6. 3| functional disability in patients with early RA that have
262 II, 5. 6. 3| future radiological change in patients with early RA that have
263 II, 5. 6. 3| of onset, at least 50% of patients were unable to hold down
264 II, 5. 6. 3| greater in studies reporting patients in the clinic setting who
265 II, 5. 6. 6| pain and quality of life in patients with noninflammatory joint
266 II, 5. 6. 6| knee osteoarthritis among patients in a health maintenance
267 II, 5. 7. 1| from other risk factors, patients with stage 4-5 CKD have
268 II, 5. 7. 1| general population, whilst patients with ESRD have a 100 times
269 II, 5. 7. 1| exceedingly frequent in patients with cardiovascular diseases
270 II, 5. 7. 1| spent on treating dialysis patients. In 2001, it was estimated
271 II, 5. 7. 1| budget was spent for ESRD patients, i.e. 0.083% of the general
272 II, 5. 7. 1| The costs of treating patients living on a transplant are
273 II, 5. 7. 1| those spent on dialysis patients (U.S. Renal Data System,
274 II, 5. 7. 2| ERA-EDTA) that collects data in patients with ESRD on RRT. Available
275 II, 5. 7. 2| During follow-up of the patients the changes in treatment
276 II, 5. 7. 2| mortality analyses included patients who started RRT over the
277 II, 5. 7. 3| children aged 0-14 was 7.1 patients pmarp (Table 5.7.3).~ ~Adults~ ~
278 II, 5. 7. 3| 3-5 CKD was 7.8 per 1000 patients x years (Kurella et al,
279 II, 5. 7. 3| for every 1000 prevalent patients with CKD in 1978. By comparison,
280 II, 5. 7. 3| developed in 1996 for every 1000 patients with CKD in 1991. A similar
281 II, 5. 7. 3| or 4 to ESRD in US white patients compared to Norwegian patients
282 II, 5. 7. 3| patients compared to Norwegian patients was 2.5. This was only modestly
283 II, 5. 7. 3| comparable, but US white patients were referred later to a
284 II, 5. 7. 3| for ESRD ranged from 57 patients pmp in Estonia to 205 patients
285 II, 5. 7. 3| patients pmp in Estonia to 205 patients pmp in Portugal (Table 5.
286 II, 5. 7. 3| to the incidence rate in patients over 65 years of age which
287 II, 5. 7. 3| improvements in survival of RRT patients (Jager and van Dijk 2007)
288 II, 5. 7. 3| for ESRD varied from 321 patients pmp in Romania to 1057 patients
289 II, 5. 7. 3| patients pmp in Romania to 1057 patients pmp in Germany (Tables 5.
290 II, 5. 7. 3| increased from 480 to 807 patients per million population (
291 II, 5. 7. 3| 2007 ). Mortality in ESRD patients is very high. Five-year
292 II, 5. 7. 3| mortality rates in incident RRT patients are 52% in all patients,
293 II, 5. 7. 3| patients are 52% in all patients, and 21%, 32% and 72% for
294 II, 5. 7. 3| and 21%, 32% and 72% for patients aged 0-14, 15-64 and over
295 II, 5. 7. 3| Five-year mortality in patients on dialysis is almost five
296 II, 5. 7. 3| outcomes in haemodialysis patients are in progress (Young et
297 II, 5. 7. 3| mortality rates in incident RRT patients per age group, gender and
298 II, 5. 7. 3| have shown that compared to patients starting dialysis in the
299 II, 5. 7. 3| cohort 1980-1984, dialysis patients in the more recent cohorts
300 II, 5. 7. 3| improvements in survival of RRT patients (Jager and van Dijk 2007)
301 II, 5. 7. 3| States.~ ~Mortality in ESRD patients is still very high. Although
302 II, 5. 7. 3| bias, the survival of RRT patients could be considerably improved
303 II, 5. 7. 4| CKD at population level. Patients with neoplasias and with
304 II, 5. 7. 4| viral hepatitis (HBC) and patients exposed to nephrotoxic drugs
305 II, 5. 7. 4| than 22% of the incident patients.~ ~Apart from international
306 II, 5. 7. 4| directions. The number of patients developing ESRD will, among
307 II, 5. 7. 4| considered is that once patients have developed ESRD, they
308 II, 5. 7. 5| Gansevoort et al, 2005) . Patients with neoplasia and with
309 II, 5. 7. 5| appears advisable. Both in patients with neoplasia and in those
310 II, 5. 7. 5| policy in Finland is that all patients should receive RRT when
311 II, 5. 7. 5| quality of care for renal patients.~· In Spain there is no
312 II, 5. 7. 5| if more than 15% of their patients fail defined limits.~· In
313 II, 5. 7. 5| especially in dialysis patients. Since 2005, it has been
314 II, 5. 7. 5| of how well they manage patients with CKD. This helps ensuring
315 II, 5. 7. 5| treatment. The registry of patients (i.e. The Statistical Yearbook
316 II, 5. 7. 6| provide support to kidney patients.~ ~Monitoring and evaluation
317 II, 5. 7. 6| quality of life of those patients for whom ESRD cannot be
318 II, 5. 7. 6| recipients compared to dialysis patients, whereas costs of treatment
319 II, 5. 7. 7| 2006): Quality of life in patients with chronic kidney disease:
320 II, 5. 7. 7| 2001): Identification of patients and risk factors in chronic
321 II, 5. 8. 1| the severity in individual patients. Its pulmonary element is
322 II, 5. 8. 1| augmentation in end-stage patients, needing long term oxygen
323 II, 5. 8. 2| in Italy: among asthmatic patients, 14% in Po Delta and 11%
324 II, 5. 8. 2| emphysema, whereas, among patients with chronic bronchitis
325 II, 5. 8. 3| a symptomatic cohort of patients born in 1919 to 1929, 1934
326 II, 5. 8. 3| sample of 25-73 year old patients from Northern Italy, AO
327 II, 5. 8. 3| areas with nearly 5 000 patients, has estimated that the
328 II, 5. 8. 3| Co-morbidity.~ ~Elderly patients frequently have multiple
329 II, 5. 8. 3| conditions and their impact on patients vary among patients and
330 II, 5. 8. 3| impact on patients vary among patients and in the same patient
331 II, 5. 8. 3| a more severe impact on patients with a given chronic disease.
332 II, 5. 8. 3| different treatment for patients with COPD (Rea et al 2004;
333 II, 5. 8. 3| common cause of death in patients with COPD in a study by
334 II, 5. 8. 3| both COPD and CVD, CVD in patients with COPD is likely to be
335 II, 5. 8. 3| analysis of mortality in COPD patients discharged from hospital
336 II, 5. 8. 3| in a study of 45 966 COPD patients aged more than 39, with
337 II, 5. 8. 3| of comorbidities in COPD patients with respect to a gender-
338 II, 5. 8. 3| to compare incident COPD patients (physician diagnosed, n =
339 II, 5. 8. 3| diagnosis of incident COPD patients related to major organ systems
340 II, 5. 8. 3| respiratory infections (RI). COPD patients were at high risk for pneumonia (
341 II, 5. 8. 3| out-patient population of patients with COPD (389 patients)
342 II, 5. 8. 3| patients with COPD (389 patients) was performed in the Netherlands (
343 II, 5. 8. 3| and 40%) than in male COPD patients (10% and 20%). Moreover,
344 II, 5. 8. 3| small Danish population of patients affected by severe COPD
345 II, 5. 8. 3| affirmed that a screening of patients with COPD would be helpful.~ ~
346 II, 5. 8. 3| Wagena et al (2004) smoker patients with asthma or COPD proved
347 II, 5. 8. 3| population of about 10 700 COPD patients, with a mean age of 67 and
348 II, 5. 8. 3| total medical cost for COPD patients in France was estimated
349 II, 5. 8. 3| Danish Patient Registry for patients admitted with COPD diagnoses
350 II, 5. 8. 3| for treatment of 40+ year patients, 10% was directed to treatment
351 II, 5. 8. 3| The net cost for COPD patients was 256 million euro (6%
352 II, 5. 8. 3| largest expenditure for patients with FEV1 below 40% is represented
353 II, 5. 8. 3| Dubrovnik during 2002-2006. COPD patients (446) were treated in hospital
354 II, 5. 8. 3| analysed parameters (number of patients, length of stay, cost of
355 II, 5. 8. 4| in the methods used for patients selection and classification.
356 II, 5. 8. 5| expected in the proportion of patients at end stage.~ ~Secondary
357 II, 5. 8. 5| after smoking cessation, patients showed an increase of 47
358 II, 5. 8. 5| smoking cessation rate in patients with AO was 16.3%, whereas
359 II, 5. 8. 5| AL in a large number of patients at a reasonable cost.~ ~
360 II, 5. 8. 6| established.~ ~Caregivers and patients need to be guided towards
361 II, 5. 8. 6| should be implemented in COPD patients.~ ~Previous studies have
362 II, 5. 8. 6| pulmonary disease (COPD) patients, yet there has been little
363 II, 5. 8. 6| people with lung cancer. Patients with COPD generally have
364 II, 5. 8. 7| 2007): The cost of treating patients with COPD in Denmark --
365 II, 5. 8. 7| population study of COPD patients compared with non-COPD controls.
366 II, 5. 8. 7| diagnosis and treatment of patients with COPD: a summary of
367 II, 5. 8. 7| health-care consumption related to patients with chronic obstructive
368 II, 5. 8. 7| in airway inflammation in patients with fixed airflow obstruction
369 II, 5. 8. 7| Health care utilization of patients with chronic obstructive
370 II, 5. 8. 7| 2007): Mortality in COPD patients discharged from hospital:
371 II, 5. 8. 7| obstructive pulmonary disease patients die from? A multiple cause
372 II, 5. 8. 7| prevalence of osteoporosis in patients with chronic obstructive
373 II, 5. 8. 7| Anxiety and depression in patients with chronic obstructive
374 II, 5. 8. 7| reduce days in hospital for patients with chronic obstructive
375 II, 5. 8. 7| Wesseling GJ (2002): Detecting patients at a high risk of developing
376 II, 5. 8. 7| out-patient population of patients with COPD. Respir Med 2006;
377 II, 5. 9. FB| Allergy and Airways Diseases Patients~ Associations~- The SCALE
378 II, 5. 9. FB| they can heavily affect the patients’ quality of life and have
379 II, 5. 9. FB| often underestimated by patients and underdiagnosed by physicians.
380 II, 5. 9. FB| be elucidated, allergic patients produce an excess of IgE
381 II, 5. 9. FB| requires more education of both patients and doctors that is crucial
382 II, 5. 9. FB| treatment. In Europe,,allergic patients are currently underestimated,
383 II, 5. 9. 1| associated with impairments in patients functioning in day-to-day
384 II, 5. 9. 1| prevalence of AR among asthmatic patients is usually over 50%. In
385 II, 5. 9. 1| symptomatic burden of AR in patients with asthma, AR can complicate
386 II, 5. 9. 1| resource usage may increase in patients with asthma and concomitant
387 II, 5. 9. 1| quality of life (QoL) of both patients and their families. For
388 II, 5. 9. 1| families. For most asthmatic patients, the disease has a deep
389 II, 5. 9. 1| Understanding asthmatic patients needs and behaviours is
390 II, 5. 9. 2| collection and including patients from all age groups with
391 II, 5. 9. 3| and the minority of the patients with early-onset asthma
392 II, 5. 9. 3| in men, P 001). Asthmatic patients in remission had an earlier
393 II, 5. 9. 3| 16.1 years, P 001) than patients with current asthma. The
394 II, 5. 9. 3| of males among asthmatic patients were most remarkable in
395 II, 5. 9. 3| emergency admissions, 8 patients died. (Lung Health in Europe,
396 II, 5. 9. 3| moment, in Europe allergic patients are underestimated, improperly
397 II, 5. 9. 3| during 2002-2006. Asthma patients (4121) were treated in hospital
398 II, 5. 9. 3| analysed parameters (number of patients, length of stay, cost of
399 II, 5. 9. 4| often underestimated by patients and under-diagnosed in all
400 II, 5. 9. 4| of symptoms in asthmatic patients. However, the risk of developing
401 II, 5. 9. 5| requires more education of both patients and doctors that is crucial
402 II, 5. 9. 5| cases are self-managed by patients with the support of general
403 II, 5. 9. 5| be strengthened with the patients, in order to create a close
404 II, 5. 9. 5| management approach for asthma patients as well as for other chronic
405 II, 5. 9. 5| very first assessment of patients. The second level is the
406 II, 5. 9. 5| specialized care in which patients are referred to and for
407 II, 5. 9. 5| clinical guidelines. Many patients are under-diagnosed and
408 II, 5. 9. 6| therapy as perceived by patients (Schipper et al, 1990).
409 II, 5. 9. 6| assessment of HRQoL in asthmatic patients has been attracting an increasing
410 II, 5. 9. 6| impact of asthma from the patients’ point of view (Baiardini
411 II, 5. 9. 6| the comparison of HRQoL of patients affected by different diseases
412 II, 5. 9. 6| health status relevant for patients with a specific disease
413 II, 5. 9. 6| quality of life in asthmatic patients: measures for prevention
414 II, 5. 10. 4| of the incriminated food. Patients and their families tend
415 II, 5. 11. 2| healthcare needs of dermatology patients in Europe.~· the Cochrane
416 II, 5. 11. 2| independent European registries of patients suffering from psoriasis
417 II, 5. 11. 3| Dermatology has to satisfy the patients with those abundant common
418 II, 5. 11. 3| 2004, altogether 11,643 patients were patch tested and the
419 II, 5. 11. 3| to gold chloride in the patients with pierced ears than in
420 II, 5. 11. 3| 0.78%) was found in 23 patients; all the reactors were women
421 II, 5. 11. 3| Last but not least, as most patients with strong sensitization
422 II, 5. 11. 3| patient, and up to 10-20% of patients with plaque psoriasis also
423 II, 5. 11. 3| have a sufficient number of patients to conduct reliable studies
424 II, 5. 11. 4| that cost being borne by patients as well as society. Small
425 II, 5. 11. 7| Adjadj L, Pawin H (2005): How patients experience psoriasis: results
426 II, 5. 14. 3| and health care funds to patients who need more intensive
427 II, 5. 14. 4| the periodontal status of patients already affected by periodontitis
428 II, 5. 15. 1| small number of affected patients. Different regions of the
429 II, 5. 15. 2| available is maintained by a patients’ umbrella organization:
430 II, 5. 15. 3| RD) affecting only a few patients worldwide, usually due to
431 II, 5. 15. 3| 350 RD affects 80% of the patients and 1,500 RD affect 95%
432 II, 5. 15. 3| 500 RD affect 95% of the patients. The estimated numbers have
433 II, 5. 15. 3| validated by data from RD patients’ registries.~ ~Today, most
434 II, 5. 15. 3| it is possible that some patients have not been recorded in
435 II, 5. 15. 3| of studied diseases, the patients have no autonomy. In terms
436 II, 5. 15. 3| treating RD and caring for patients has not been documented.
437 II, 5. 15. 3| reimbursement, population of patients treated etc.). The survey
438 II, 5. 15. 4| systems to the needs of the RD patients’ community. A first inventory
439 II, 5. 15. 4| empowerment and involvement of patients and patients' organisations.
440 II, 5. 15. 4| involvement of patients and patients' organisations. Following
441 II, 5. 15. 4| of diagnosis and care of patients with RD; accelerate research
442 II, 5. 15. 4| field of RD and OD; empower patients with RD at individual and
443 II, 5. 15. 5| identified the needs of patients affected with a RD and have
444 II, 5. 15. 5| or expertise; will offer patients the highest possible chance
445 II, 5. 15. 5| level of empowerment of patients. RD patients and their organizations
446 II, 5. 15. 5| empowerment of patients. RD patients and their organizations
447 II, 5. 15. 5| research policies and projects. Patients are directly involved in
448 II, 6. 3. 1| laboratory in asymptomatic patients either by chance, as a more
449 II, 6. 3. 1| activity to find asymptomatic patients rather than reflecting the ‘
450 II, 6. 3. 2| revolutionised the way we treat patients with bacterial infections
451 II, 6. 3. 2| surveys, the total number of patients acquiring a HCAI in the
452 II, 6. 3. 2| the infection. Of 87 000 patients staying more than two days
453 II, 6. 3. 2| such as intensive care patients) or infection types (surgical
454 II, 6. 3. 3| 25%) or cancer (5%), and patients with chronic infection serve
455 II, 6. 3. 4| detection of infectious patients and treatment for at least
456 II, 6. 3. 4| steadily increasing among TB patients.~· Countries in central
457 II, 6. 3. 6| majority of cases, namely those patients who do not seek healthcare
458 II, 6. 3. 6| in children, and 3–5% of patients die. The main reservoir
459 II, 6. 3. 6| life-threatening in immuno-deficient patients. Outbreaks have been reported
460 II, 6. 3. 7| asymptomatic, the remaining patients develop severe multi-system
461 II, 6. 3. 7| available, and up to 30% of patients may die. In recent years,
462 II, 7. 3. 4| fatal (hospital treated patients) home and leisure accidents
463 II, 7. 3. 5| injuries of hospital treated patients.~ ~For sure, tackling the
464 II, 7. 3. 5| violence of hospital treated patients.~ ~The WHO World Report
465 II, 7. 4. 6| protective factors. For adult patients who have attempted suicide
466 II, 7. 5 | effective advisors towards their patients.~· Advocacy: Health administrators
467 II, 8. 2. 1| are able to identify those patients on their registers who have
468 II, 8. 2. 1| utilization patterns with those of patients from the general population (
469 II, 8. 2. 1| presented evidence that patients with intellectual disabilities
470 II, 8. 2. 1| prescribed medications than patients of the same age and gender
471 II, 9 | disability than more educated patients. Numerous studies demonstrate
472 II, 9. 3. 1| improve survival in older patients (European Heart Network,
473 II, 9. 3. 1| as many as one-fourth of patients with deep venous thrombosis.
474 II, 9. 3. 1| highly variable. In some patients with bleeding, the endometrial
475 II, 9. 3. 1| important to identify and treat patients with recurrent infections
476 II, 9. 3. 1| disability than more educated patients. Numerous studies demonstrate
477 II, 9. 3. 1| registries study on cancer patients’ survival and care~Euro-REVES~
478 II, 9. 4. 3| as high as 50 to 70% in patients over 75 years of age. A
479 II, 9. 4. 3| of stroke care for older patients in thirteen hospitals in
480 II, 9. 4. 3| 25% of all breast cancer patients are aged 75 or older. Data
481 II, 9. 4. 3| what kind of care these patients are seeking/requiring. There
482 II, 9. 4. 3| trials conducted on older patients. Specific clinical trials
483 II, 9. 4. 3| males. In a small sample of patients resident in Lombardy, the
484 II, 9. 4. 3| retrospective study of 239 new patients, 60 years of age and older,
485 II, 9. 4. 3| Over half (121) of the 239 patients were single, divorced, separated
486 II, 9. 4. 3| women over 40 made up 7% of patients diagnosed with HIV, up 2%
487 II, 9. 4. 5| Medicine. A large proportion of patients attending general hospitals
488 II, 9. 4. 5| cross-border mobility of patients and enlargement. The Community’
489 II, 9. 4. 5| health professionals and patients integrate cost considerations
490 II, 9. 4. 5| an important subgroup. As patients, they may take on a passive
491 II, 9. 4. 7| Abstract: Older stroke patients in Europe: stroke care and
492 II, 9. 5. 3| State (Eurostat, 2006).~ ~Patients~ ~With increasing life expectancies,
493 III, 10. 2. 1| of some countries to help patients stop smoking. Bupropion
494 III, 10. 2. 1| treatment course of injured patients and can lead to surgical
495 III, 10. 2. 1| cobalamin) deficiency in elderly patients. CMAJ 171: 251-259.~ ~Brown
496 III, 10. 2. 2| mg/dL in very high risk patients to 160 mg/dL in very low
497 III, 10. 3. 4| risk, with evacuation of patients and vulnerable groups representing
498 III, 10. 3. 4| by an increased number of patients seeking emergency services .
499 III, 10. 5. 2| greater number of elderly patients. In contrast, a Dutch study
500 III, 10. 5. 2| England identified rural patients as associated to better
